Pennant Group, INC 8-K filings

The Pennant Group, Inc. held its Annual Meeting of Stockholders on May 14, 2026, where directors were elected and the company's independent auditor was ratified.

The Pennant Group, Inc. announced robust first quarter 2026 financial results, driven by significant revenue growth and improved operational performance across its home health, hospice, and senior living segments.

The Pennant Group, Inc. announced record-breaking financial and operational results for the fourth quarter and full fiscal year 2025, driven by significant growth in both home health, hospice, and senior living segments.

The Pennant Group filed an 8-K/A detailing the financial statements and pro forma impact of its recent acquisition of home health and hospice subsidiaries from Amedisys and UnitedHealth.

The Pennant Group, Inc. announced strong third-quarter 2025 results with record operational metrics and an updated positive full-year guidance, following a major acquisition.

The Pennant Group, Inc. has expanded its credit facility by $100 million to $350 million, enhancing financial flexibility for future growth.

The Pennant Group, Inc. completed its $146.5 million acquisition of 54 home health, hospice, and personal care operations in Tennessee, Georgia, and Alabama from UnitedHealth Group.

The Pennant Group, Inc. amended its April 2025 purchase agreement to acquire additional home health and hospice entities and assets, increasing the total consideration to $146.5 million.

The Pennant Group completed the acquisition of 54 home health, hospice, and personal care locations in Tennessee, Georgia, and Alabama from UnitedHealth Group and Amedisys for $146.5 million.

The Pennant Group, Inc. announced robust second quarter 2025 financial results, exceeding prior year performance across key metrics and raising its full-year 2025 guidance.

The Pennant Group's annual meeting on May 16, 2025, resulted in the election of directors, approval of officer exculpation, an incentive plan, ratification of the auditor, and an advisory vote on executive compensation.

The Pennant Group, Inc. announced a strong first quarter in 2025, with total revenue increasing by 33.7% year-over-year to $209.8 million and GAAP diluted earnings per share of $0.22.

The Pennant Group, Inc. announces the acquisition of home health, hospice, and palliative care assets from UnitedHealth Group and Amedisys for $102.5 million.

The Pennant Group announced impressive Q4 and fiscal year 2024 results, highlighted by a 27.6% increase in total revenue and significant growth in adjusted earnings per share.

The Pennant Group has completed its two-stage acquisition of Signature Healthcare at Home assets, finalizing the purchase of Oregon operations on January 1, 2025.

The Pennant Group announced a robust third quarter with a 28.9% increase in revenue and a 41.6% increase in net income compared to the same period last year.

The Pennant Group, Inc. successfully closed a public offering of 4,025,000 shares of its common stock, generating net proceeds of approximately $118.5 million.

The Pennant Group announced a significant increase in revenue and net income for the second quarter of 2024, driven by strong performance in both home health and senior living segments.

The Pennant Group has increased its credit facility by $100 million, bringing the total to $250 million, to support future growth and acquisitions.

The Pennant Group has agreed to purchase the assets of Signature Healthcare at Home for $80 million, expanding its presence in the Pacific Northwest.

The Pennant Group held its annual meeting on May 23, 2024, electing three Class II directors and ratifying Deloitte & Touche LLP as its independent auditor.

The Pennant Group announced a robust first quarter in 2024, with significant increases in revenue, net income, and adjusted earnings per share compared to the same period last year.

The Pennant Group will participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference on March 13, 2024, with a fireside chat featuring key executives.

The Pennant Group announced robust financial results for the fourth quarter and full year 2023, with significant revenue and earnings growth across its home health, hospice, and senior living segments.